drugset

drugset / Trial / NCT00040274

A Study of DPC 817 in HIV-Infected Males

NCT00040274 ↗

Phase 1 Completed 30 enrolled Pharmasset

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate DPC 817. The safety, dosages, and how the body responds to the drug will be studied.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dexelvucitabine	Small molecule	—	Oral

Indications